In a 62-year-old male with Down syndrome, anxiety disorder, major depression, and dementia who is in rehabilitation after recent hospitalization for altered mental status and is currently on risperidone 1 mg at bedtime and buspirone (Buspar) 10 mg in the morning and 20 mg at night, but remains restless, confused, and anxious with frequent yelling despite a one‑to‑one sitter, what management steps should be taken?

Optimize Risperidone Dosing and Consider Adding Trazodone for Persistent Agitation

Your patient's risperidone dose of 1 mg at bedtime is appropriate, but the persistent restlessness and anxiety despite buspirone suggests you need to increase the risperidone dose and/or add a mood-stabilizing agent like trazodone. The current buspirone regimen (10 mg AM, 20 mg PM) is already at a reasonable dose but is clearly insufficient for his level of agitation.

Immediate Management Steps

1. First, Rule Out Medical Causes of Delirium

Before adjusting medications, ensure you've excluded:

• Infection (UTI, pneumonia)
• Metabolic derangements
• Medication toxicity or withdrawal
• Pain
• Constipation/urinary retention

The recent hospitalization for altered mental status makes ongoing delirium a critical consideration.

2. Optimize Risperidone Dosing

Increase risperidone gradually to 1.5-2 mg daily in divided doses 1. The guidelines specifically state that for dementia-related agitation, risperidone can be titrated up to 2-3 mg per day in divided doses, with current research supporting low dosages 1. His current 1 mg at bedtime is at the lower end of the therapeutic range.

• Start by splitting the dose: 0.5 mg in morning, 1 mg at bedtime
• After 3-5 days, if tolerated, increase to 1 mg twice daily
• Monitor closely for extrapyramidal symptoms (EPS), which can occur at 2 mg per day 1

Critical caveat: In elderly patients with dementia, risperidone carries a black box warning for increased mortality and cerebrovascular events 2. However, given his dangerous restlessness requiring a 1:1 sitter and the absence of violence, the benefit-risk ratio may still favor treatment.

3. Add Trazodone as a Mood-Stabilizing Agent

Consider adding trazodone 25 mg at bedtime, titrating up to 50-100 mg 1. The guidelines specifically recommend trazodone as a mood-stabilizing/antiagitation drug that is useful as an alternative or adjunct to antipsychotics for control of severe agitated, repetitive, and combative behaviors 1.

• Start: 25 mg at bedtime
• Increase by 25 mg every 3-5 days as tolerated
• Maximum: 200-400 mg per day in divided doses
• Use with caution if he has cardiac history (premature ventricular contractions) 1

Trazodone has the advantage of addressing both agitation and sleep disturbances without the anticholinergic burden that would worsen his confusion.

4. Reassess Buspirone's Role

Buspirone is only useful for mild to moderate agitation and may take 2-4 weeks to become effective 1. Given his severe symptoms requiring a 1:1 sitter, buspirone alone is insufficient. However, there is specific evidence supporting buspirone use in Down syndrome for anxiety 3, 4, and it has shown efficacy in dementia-related behavioral disturbances 5.

Do not discontinue buspirone abruptly, but recognize its limitations. The current dosing (10 mg AM, 20 mg PM) is reasonable but could be increased to the maximum of 20 mg three times daily if you choose to continue it 1.

Alternative Considerations

If Risperidone Increase Fails or Causes EPS:

Switch to quetiapine 12.5 mg twice daily, titrating up to 25-50 mg twice daily 1. Quetiapine is more sedating and has lower risk of EPS, though it carries risk of orthostatic hypotension 1. Recent evidence suggests quetiapine has the lowest frequency of adverse events among antipsychotics in older adults 6.

If Behavioral Symptoms Persist:

Consider divalproex sodium (Depakote) 125 mg twice daily 1. It is generally better tolerated than other mood stabilizers and is specifically recommended for control of severe agitated, repetitive, and combative behaviors 1. Titrate to therapeutic blood level (40-90 mcg/mL) while monitoring liver enzymes and platelets.

Critical Warnings and Monitoring

Down Syndrome-Specific Considerations:

• Individuals with Down syndrome have high anticholinergic burden risk and premature aging 7
• They are particularly vulnerable to cognitive decline from anticholinergic medications
• Risperidone and buspirone have been specifically studied and used in this population 3, 4, 7

Avoid These Medications:

• Benzodiazepines (especially midazolam): Highest risk of adverse events in older adults with agitation 6. Paradoxical agitation occurs in 10% of patients 1
• Typical antipsychotics (haloperidol): 50% risk of tardive dyskinesia after 2 years in elderly patients 1
• Anticholinergic agents: Will worsen confusion and cognitive function

Monitor Closely For:

• Extrapyramidal symptoms: Rigidity, tremor, shuffling gait
• Sedation: May worsen confusion or increase fall risk
• Orthostatic hypotension: Especially with quetiapine or trazodone
• QTc prolongation: Baseline and follow-up ECG if using higher doses of antipsychotics
• Cerebrovascular events: New focal neurological signs, sudden change in mental status

Reassessment Timeline

• Week 2: Assess early response. Early response (by week 2) predicts week 8-12 improvement 8
• Week 4-8: Full therapeutic trial requires at least 4-8 weeks 1
• After 9 months: Consider dose reduction to reassess need for continued medication 1

Non-Pharmacologic Interventions (Essential Adjuncts)

While medications are necessary given the severity, simultaneously implement:

• Structured daily routine
• Minimize environmental stimuli
• Ensure adequate pain control
• Address sensory deficits (hearing aids, glasses)
• Maintain sleep hygiene
• Consider music therapy or other calming activities

The goal is to use the lowest effective dose for the shortest duration while addressing reversible causes and maximizing non-pharmacologic interventions.